New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 17, 2012
09:09 EDTQCOR, REGN, ALXN, GILD, ONXX, DNDNLazard Capital previews Q3 earnings in BioPharma space
Lazard Capital believes BioPharma companies most likely to beat Q3 top-line consensus expectations are Questcor (QCOR), Regeneron (REGN), Alexion (ALXN), and Gilead (GILD). The firm raised its price target for Onyx Pharmaceuticals (ONXX) to $110 from $90 and keeps a Buy rating on the stock. Lazard Capital also lowered its price target for Dendreon (DNDN) to $3 from $4 while keeping a Sell rating on shares.
News For QCOR;REGN;ALXN;GILD;ONXX;DNDN From The Last 14 Days
Check below for free stories on QCOR;REGN;ALXN;GILD;ONXX;DNDN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 24, 2013
11:44 EDTREGNStocks with call strike movement; NFLX REGN
Netflix (NFLX) June 255 call option implied volatility increased 1% to 44, Regeneron (REGN) September 300 call option implied volatility decreased 2% to 43 according to IVolatility.
07:20 EDTGILDCelgene, Gilead, and Biogen could go much higher, says Bernstein
Subscribe for More Information
May 23, 2013
10:27 EDTGILDGilead has a conference call hosted by JPMorgan
Subscribe for More Information
May 22, 2013
12:25 EDTREGNStocks with call strike movement; GME REGN
Subscribe for More Information
May 21, 2013
16:51 EDTGILDGilead's sofosbuvir gets EMA validation, now under assessment
Subscribe for More Information
13:36 EDTONXXOnyx Pharmaceuticals mentioned cautiously at BofA/Merrill
Subscribe for More Information
May 20, 2013
19:01 EDTREGNOn The Fly: After Hours Movers
Subscribe for More Information
17:26 EDTREGNRegeneron, Genentech, Sanofi enter into 'Zaltrap agreement'
Subscribe for More Information
17:20 EDTREGNRegeneron,, Bayer, Genentech resolve certain patent disputes
Subscribe for More Information
07:34 EDTGILDUBS to host a conference
Subscribe for More Information
07:28 EDTREGNAmerican Thoracic Society to hold a conference
Subscribe for More Information
May 17, 2013
10:07 EDTREGNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:16 EDTREGNRegeneron initiated with a Neutral at UBS
Subscribe for More Information
06:33 EDTREGNAmerican Thoracic Society to hold a conference
Subscribe for More Information
May 16, 2013
11:50 EDTGILDCelgene, Gilead lower after new data published at ASCO
Subscribe for More Information
May 15, 2013
18:32 EDTGILDGilead announces response data from Phase 2 study of Idelalisib
Subscribe for More Information
11:20 EDTQCOROptions with increasing implied volatility: QCOR MYGN GDI
Subscribe for More Information
05:57 EDTQCORStocks with implied volatility movement; SODA QCOR
Subscribe for More Information
05:39 EDTREGNSanofi, Regeneron announce patient enrollment in two Phase 3 trials
Subscribe for More Information
May 14, 2013
07:34 EDTREGNRegeneron outlook positive, says RBC Capital
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.